Want to see LQDA full AI Analyst Report?

Liquidia Technologies (LQDA) Stock Forecast & Price Target

792 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

LQDA Analyst Ratings

Moderate Buy

5 Buy

2 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Liquidia

Technologies

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

LQDA Stock 12 Month Forecast

Average Price Target

$106.71

▲(23.77% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Liquidia Technologies in the last 3 months. The average price target is $106.71 with a high forecast of $130.00 and a low forecast of $90.00. The average price target represents a 23.77% change from the last price of $86.22.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","131":"$131","44.75":"$44.8","73.5":"$73.5","102.25":"$102.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":130,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$130.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":106.71428571428571,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$106.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,44.75,73.5,102.25,131],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,84.11,87.64,91.17,94.7,98.23,101.76,105.28999999999999,108.82,112.35,115.88,119.41,122.94,126.47,{"y":130,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,84.11,85.84879120879121,87.58758241758241,89.32637362637362,91.06516483516484,92.80395604395605,94.54274725274725,96.28153846153846,98.02032967032966,99.75912087912087,101.49791208791208,103.2367032967033,104.9754945054945,{"y":106.71428571428571,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,84.11,84.56307692307692,85.01615384615384,85.46923076923076,85.9223076923077,86.37538461538462,86.82846153846154,87.28153846153846,87.73461538461538,88.1876923076923,88.64076923076922,89.09384615384616,89.54692307692308,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.68,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.05,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.36,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.05,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.49,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.21,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.94,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.47,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.14,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.745,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.32,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.11,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$130.00

Average Price Target$106.71

Lowest Price Target$90.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Benjamin Burnett

Wells Fargo

$108

Buy

25.26%

Upside

Reiterated

08/19/26

Liquidia Technologies (LQDA) Gets a Buy from Wells Fargo

Andrew Fein

H.C. Wainwright

$130

Buy

50.78%

Upside

Reiterated

08/14/26

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (NASDAQ: LQDA), AbbVie (NYSE: ABBV) and Establishment Labs Holdings (NASDAQ: ESTA)

Ryan Deschner

Raymond James

$106

Buy

22.94%

Upside

Reiterated

08/13/26

Analysts Are Bullish on These Healthcare Stocks: Unicycive Therapeutics (UNCY), Liquidia Technologies (LQDA)

Julian Harrison

BTIG

$109→$111

Buy

28.74%

Upside

Reiterated

08/12/26

Analyst Lifts Liquidia Price Target to $111 on Strong Yutrepia Momentum and Expanding Clinical Platform

Jason Gerberry

Bank of America Securities

$79→$92

Hold

6.70%

Upside

Reiterated

08/12/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Liquidia Technologies (NASDAQ: LQDA) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Serge Belanger

Needham

$110

Buy

27.58%

Upside

Reiterated

08/12/26

Analyst Sees Yutrepia’s Strong Commercial Trajectory and Liquidia Pipeline Supporting Buy Rating and Billion-Dollar Sales Outlook

Gaurav Maini

LifeSci Capital

$101→$90

Hold

4.38%

Upside

Downgraded

08/12/26

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (NASDAQ: BNGO), Liquidia Technologies (NASDAQ: LQDA) and PolyPid (NASDAQ: PYPD)

Amy Li

Jefferies

$57→$60

Buy

-30.41%

Downside

Assigned

05/11/26

Liquidia price target raised to $60 from $57 at JefferiesLiquidia price target raised to $60 from $57 at Jefferies

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Benjamin Burnett

Wells Fargo

$108

Buy

25.26%

Upside

Reiterated

08/19/26

Liquidia Technologies (LQDA) Gets a Buy from Wells Fargo

Andrew Fein

H.C. Wainwright

$130

Buy

50.78%

Upside

Reiterated

08/14/26

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (NASDAQ: LQDA), AbbVie (NYSE: ABBV) and Establishment Labs Holdings (NASDAQ: ESTA)

Ryan Deschner

Raymond James

$106

Buy

22.94%

Upside

Reiterated

08/13/26

Analysts Are Bullish on These Healthcare Stocks: Unicycive Therapeutics (UNCY), Liquidia Technologies (LQDA)

Julian Harrison

BTIG

$109→$111

Buy

28.74%

Upside

Reiterated

08/12/26

Analyst Lifts Liquidia Price Target to $111 on Strong Yutrepia Momentum and Expanding Clinical Platform

Jason Gerberry

Bank of America Securities

$79→$92

Hold

6.70%

Upside

Reiterated

08/12/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Liquidia Technologies (NASDAQ: LQDA) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Serge Belanger

Needham

$110

Buy

27.58%

Upside

Reiterated

08/12/26

Analyst Sees Yutrepia’s Strong Commercial Trajectory and Liquidia Pipeline Supporting Buy Rating and Billion-Dollar Sales Outlook

Gaurav Maini

LifeSci Capital

$101→$90

Hold

4.38%

Upside

Downgraded

08/12/26

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (NASDAQ: BNGO), Liquidia Technologies (NASDAQ: LQDA) and PolyPid (NASDAQ: PYPD)

Amy Li

Jefferies

$57→$60

Buy

-30.41%

Downside

Assigned

05/11/26

Liquidia price target raised to $60 from $57 at JefferiesLiquidia price target raised to $60 from $57 at Jefferies

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Liquidia Technologies

3 Months

Serge BelangerNeedham

Success Rate

23/32 ratings generated profit

Average Return

+23.43%

Copying Serge Belanger's trades and holding each position for 3 Months would result in 71.88% of your transactions generating a profit, with an average return of +23.43% per trade.

1 Year

Julian HarrisonBTIG

Success Rate

28/32 ratings generated profit

Average Return

+97.28%

Copying Julian Harrison's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +97.28% per trade.

2 Years

Serge BelangerNeedham

Success Rate

31/32 ratings generated profit

Average Return

+222.25%

Copying Serge Belanger's trades and holding each position for 2 Years would result in 96.88% of your transactions generating a profit, with an average return of +222.25% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LQDA Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, LQDA has received 15 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. LQDA average Analyst price target in the past 3 months is 106.71.

Each month's total comprises the sum of three months' worth of ratings.

LQDA Financial Forecast

LQDA Earnings Forecast

Next quarter’s earnings estimate for LQDA is $0.88 with a range of $0.53 to $1.19. The previous quarter’s EPS was $0.74. LQDA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year LQDA has Performed in-line its overall industry.

LQDA Sales Forecast

Next quarter’s sales forecast for LQDA is $205.91M with a range of $192.73M to $213.27M. The previous quarter’s sales results were $171.68M. LQDA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year LQDA has Performed in-line its overall industry.

LQDA Stock Forecast FAQ

What is LQDA’s average 12-month price target, according to analysts?

Based on analyst ratings, Liquidia Technologies’s 12-month average price target is 106.71.

What is LQDA’s upside potential, based on the analysts’ average price target?

Liquidia Technologies has 23.77% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is LQDA a Buy, Sell or Hold?

Liquidia Technologies has a consensus rating of Moderate Buy which is based on 5 buy ratings, 2 hold ratings and 0 sell ratings.

What is Liquidia Technologies’s price target?

The average price target for Liquidia Technologies is 106.71. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $130.00 ,the lowest forecast is $90.00. The average price target represents 23.77% Increase from the current price of $86.22.

What do analysts say about Liquidia Technologies?

Liquidia Technologies’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of LQDA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Liquidia Technologies (LQDA) Stock Forecast & Price Target

LQDA Analyst Ratings

LQDA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Liquidia Technologies

LQDA Analyst Recommendation Trends

LQDA Financial Forecast

LQDA Earnings Forecast

LQDA Sales Forecast

LQDA Stock Forecast FAQ

Detailed List of Analyst Forecasts